Eosinophils are white blood cells specialized for fighting parasitic infections and mediating allergic responses. They typically comprise 1-4% of white blood cells, one of the smaller populations in healthy individuals.
Elevated eosinophils (eosinophilia) most commonly indicates allergies, asthma, eczema, or parasitic infections. Persistent eosinophilia without obvious allergy warrants investigation for parasites, certain medications, or hypereosinophilic syndromes. Low eosinophils are rarely clinically significant. This marker is particularly useful for evaluating unexplained GI symptoms (possible parasitic cause) or when allergic/atopic conditions are suspected.
Optimal Eosinophils: 1-4 %.
Typically re-tested every 12 weeks.
The percentage and the absolute count answer slightly different questions, and both are read next to the rest of your complete blood count rather than on their own.
An eosinophil is a granulocyte, a white blood cell made in the bone marrow that stores pre-formed inflammatory proteins inside its granules and releases them during allergic, antiparasitic and tissue repair responses[1].
The name comes from the way those granules soak up eosin, a red laboratory dye, which is how they were first distinguished under a microscope. Production in the marrow is driven by signalling molecules, interleukin-5 being the best described of them. Once released, eosinophils circulate only briefly before migrating into tissue under the pull of chemokines known as eotaxins. They settle in the gut lining, the airways, the skin and other barrier surfaces, and the gastrointestinal tract carries a resident eosinophil population even in health[2].
Their granule proteins, including major basic protein, eosinophil cationic protein and eosinophil peroxidase, are built to damage multicellular parasites. The same cargo can irritate host tissue when it is released repeatedly in the wrong place, which is why these cells sit at the centre of allergic inflammation. More recent work has broadened the picture considerably, describing eosinophils as regulatory cells that help shape local immune tone, tissue remodelling and repair rather than acting purely as destructive effectors[3].
One practical consequence matters for reading your result. Because most eosinophils live in tissue, a blood count only samples the circulating minority. A normal blood value does not rule out tissue eosinophilia, and a raised blood value does not tell you which tissue is involved.
It matters because the count behaves as a window into type 2 inflammation, the immune pattern that underlies much allergic airway and skin disease, and it may carry prognostic information across several chronic conditions.
In asthma, blood eosinophils have been studied as a marker of disease behaviour rather than simply a bystander. Research in childhood asthma suggests that blood eosinophil levels, alongside fractional exhaled nitric oxide, carry prognostic and predictive value for how the airway disease evolves and responds to inhaled therapy[4]. Work in children receiving mepolizumab, a prescription biologic medicine that targets interleukin-5 signalling, found that activated eosinophils in sputum were associated with exacerbations even where blood counts had fallen[5]. Whether any biologic is appropriate for a given person is a decision a licensed provider makes after evaluating them.
In chronic obstructive pulmonary disease the marker has been debated for years. Reviews have asked whether blood eosinophils are just another biomarker or a genuinely useful way to separate patients with different inflammatory patterns[6], and later analyses describe the count as associated with exacerbation risk and with corticosteroid responsiveness in people with COPD[7]. More recent reviews continue to examine how the count may guide long-term management choices in that population[8].
Skin is the other major territory. Eosinophils and their granule proteins have long been described in the inflamed skin and circulation of people with atopic dermatitis, where counts often track disease activity[9]. In bullous pemphigoid, an autoimmune blistering condition, eosinophils appear to participate directly in blister formation rather than arriving as passive passengers[10], which is why they have been studied as a therapeutic target in that disease[11].
There is also early and genuinely unsettled work in tumour immunology. Studies indicate an association between eosinophils and the response to immunotherapy in melanoma, though the mechanisms and the clinical usefulness of the observation are still being worked out[12].
Most laboratories regard an eosinophil percentage of roughly 0 to 6 % of total white cells as within the typical reference range, and FitScript's optimal range sits narrower at 1 to 4 %.
| Measure | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Eosinophils (% of white cells) | 0 to 6 % | 1 to 4 % |
| Absolute eosinophil count | commonly up to about 0.5 ×10⁹/L (500 cells/µL) | not expressed as a percentage target |
Brazil's National Health Survey (2014 to 2015) set blood count reference intervals from 2,803 adults aged 18 and older. Absolute eosinophil counts were statistically different between men and women, though the upper limits were close.[13]
| Sex | Age | Reference range (cells/mm³) |
|---|---|---|
| Men | 18 and older | 17.5 to 676.4 |
| Women | 18 and older | 11.7 to 671.6 |
The paper reports absolute eosinophil counts in cells/mm³ (not a percentage), using nonparametric lower and upper limits split by sex. Labs report eosinophils in different units and with different methods, so your own lab's printed range is the one to read your result against.
Reference ranges vary by laboratory, age and sex, so read the range printed on your own report first. FitScript's optimal range is an optimization target used to flag drift earlier, not a diagnostic cut-off, and a value outside it is not a disease label.
The two lines on your report are related by simple arithmetic. The absolute count, often printed as Eosinophils Abs, is the total white cell count multiplied by the eosinophil percentage. That is why a percentage can look high while the absolute count stays within range, usually because the total white count is low, and why the absolute count is generally the more informative of the two. When people search for high absolute eosinophils, this is the number they are reading.
Clinicians commonly describe a persistent absolute count above roughly 1.5 ×10⁹/L as marked eosinophilia, a level that prompts a broader assessment rather than watchful waiting. A single modestly raised value in an otherwise well person is a different situation from a sustained, substantial elevation.
A high eosinophil result means a larger than usual share of these cells is circulating at the moment the blood was drawn, which most often reflects allergic or parasite-driven immune activity somewhere in the body.
Many people with a mildly raised count report nothing at all and find the result incidentally. When symptoms do accompany it, they tend to belong to the underlying process rather than the cells themselves. People commonly describe itching, rash or eczema flares, nasal congestion and sneezing, wheeze, cough or chest tightness, reflux-like or abdominal symptoms, and sometimes fatigue.
Common contributors include seasonal and perennial allergy, asthma and other airway disease, atopic dermatitis and related skin inflammation[9], drug hypersensitivity reactions, and parasitic infection, which remains a leading cause worldwide. Eosinophilic conditions of the gut can raise counts, reflecting the tissue population that normally lives there[2]. Autoimmune blistering disease is a less common contributor[10]. Adrenal insufficiency, where cortisol output is low, is associated with higher eosinophil counts because cortisol normally suppresses them. Uncommonly, a marked and persistent elevation points toward a primary blood disorder or hypereosinophilic syndrome, which is exactly why sustained high values get investigated rather than monitored indefinitely.
The long-term consideration is tissue exposure. Where eosinophilic inflammation continues for years, the granule proteins and growth factors these cells release are associated with remodelling of the affected tissue, including airway wall changes in chronic asthma and, in sustained marked eosinophilia, injury to organs such as the heart, lungs, skin or nerves. That is a reason to identify a driver, not a reason to assume harm from a single number.
A sensible next step is to look at the trend rather than the snapshot. A repeat count after several weeks, read alongside symptoms, medication history, travel history and the rest of the blood count, usually clarifies a great deal. A markedly raised or persistently rising count, or one accompanied by breathlessness, weight loss, fever, rash or night sweats, is worth discussing with a clinician promptly.
A low eosinophil result, sometimes reported as Eosinophils Abs low or as 0 %, is usually unremarkable and rarely carries the same weight as a high one.
People with low counts typically report no symptoms attributable to the finding. Because the lower end of the standard reference range reaches zero, a result of zero can be entirely ordinary in a healthy person, particularly on a sample drawn in the morning.
The most frequent explanations are physiological or pharmacological. Cortisol suppresses circulating eosinophils, so acute stress, acute infection, surgery, trauma and steroid medicines all push the number down. Conditions involving high endogenous cortisol produce the same pattern. Biologic medicines that target interleukin-5 signalling deliberately lower eosinophils in people with severe eosinophilic asthma, and whether such a medicine is appropriate is assessed by a licensed provider.
Long term, an isolated low count is not established as a health concern in its own right. Given the regulatory and homeostatic roles now described for these cells[3], the consequences of sustained depletion remain an active research question rather than a settled one. What makes a low value worth a second look is context, particularly a simultaneously low total white cell count or a pattern of frequent infection.
Several ordinary, non-disease factors move this number, which is one reason a single reading is interpreted cautiously.
Timing matters. Eosinophil counts follow a daily rhythm that runs roughly opposite to cortisol, tending to be lowest in the morning and higher overnight, so two draws taken at different hours can differ meaningfully. Acute illness, physical stress and strenuous exercise in the preceding days can also shift the result, usually downward in the short term.
Medication is the next common influence. A wide range of prescription medicines can raise it as part of a hypersensitivity reaction, sometimes well before a rash appears, which is why a medication review is a standard part of working out a new elevation. Any change to a prescription is decided by a licensed provider, not by a lab value alone.
Exposure and environment contribute too. Allergen season, a new pet, mould exposure, smoking and recent travel to regions where parasitic infection is common are all associated with changes in the count. Sample handling and the specific analyser a laboratory uses add a small amount of variation on top, so comparing results across different labs is less reliable than tracking the same lab over time. Fasting is not generally required for a complete blood count.
Day-to-day habits that influence allergic inflammation, such as reducing allergen exposure and stopping smoking, are covered in depth in FitScript's dedicated question-and-answer guide for this marker. This page stays with definitions, ranges and interpretation.
Eosinophils are measured as part of the complete blood count with differential, a standard panel that reports total white cells and the proportion and absolute number of each white cell type on a single draw.
That panel sits inside FitScript's membership testing, which covers 150+ biomarkers tested per year, so the count is read in series rather than as an isolated event. Atlas, FitScript's AI health advisor, interprets each result against both the laboratory reference range and the optimal range, and explains how the marker sits relative to the rest of your blood count and your reported symptoms. The personalised output Atlas writes from your biology is your FitScript, and it updates as new results arrive.
Repeat testing is where this particular marker earns its value. A one-off 7 % is a question; the same value across three draws spanning a season, with symptoms that track it, is a pattern. Where a result suggests that medical assessment or a prescription option should be considered, a licensed provider reviews the member and decides whether anything is appropriate.
Eosinophils are interpreted as one line of a larger picture, and the most useful companions come from the same draw.
Total WBCs anchor the percentage, since the same 6 % means very different absolute numbers at a low versus a high white count. Basophils are the other granulocyte involved in allergic signalling, and the two often move together in atopic patterns. Hemoglobin, RBC and Hematocrit round out the red cell side of the same panel and help distinguish a true white cell change from haemoconcentration or an underlying anaemia that shifts proportions. Vitamin D (25-OH) is worth having in view because vitamin D status may relate to allergic and airway inflammation, though the direction and clinical weight of that relationship are not settled. All of these markers appear together on FitScript Essential, the baseline panel that establishes a starting point for tracking.
A high eosinophil count is a clue about immune activity, most often allergic, parasitic or drug related, and it is read alongside symptoms, medication history and the rest of the complete blood count rather than alone. A low or zero count is usually unremarkable and frequently reflects cortisol, stress or steroid medication. What changes the interpretation is persistence, magnitude and context, which is why trend data beats any single draw.
This article is educational and is not medical advice. Discuss your own results, and any treatment decision that might follow from them, with a clinician or licensed provider who can review your full history.
It means a larger than usual share of these allergy-related white cells was circulating when the sample was drawn. The most common explanations are allergy, asthma or other airway inflammation, skin conditions such as eczema, a drug hypersensitivity reaction, or parasitic infection. A single raised value is a prompt to look further, not a diagnosis, and it is read alongside your symptoms, medications and the rest of the blood count.
The percentage is the share of your total white cells that are eosinophils. The absolute count, often printed as Eosinophils Abs, is that percentage multiplied by the total white cell count, giving the actual number of cells per volume of blood. The absolute number is generally more informative, because a percentage can read high simply when the total white count is low.
Most laboratories regard roughly 0 to 6 % of total white cells as typical, and an absolute count commonly up to about 0.5 ×10⁹/L. FitScript's optimal range is narrower at 1 to 4 %, used as an optimization target rather than a diagnostic cut-off. Reference ranges vary by laboratory, age and sex, so compare your value against the range printed on your own report.
A mildly raised count in someone who feels well is a common and often transient finding, frequently linked to allergy season or a recent reaction. It is better described as suboptimal than alarming. What raises its importance is persistence over repeated draws, a markedly elevated absolute count, or accompanying symptoms such as breathlessness, rash, weight loss or fever, which are worth discussing with a clinician promptly.
Yes. Eosinophil counts follow a daily rhythm that runs roughly opposite to cortisol, tending to be lowest in the morning and higher overnight. Acute stress, acute illness, surgery and strenuous exercise all push the number down temporarily. Drawing repeat samples at a similar time of day, at the same laboratory, makes trends much easier to interpret.
Usually very little on its own. Because the bottom of the standard range reaches zero, a result of zero can be entirely normal. A low value becomes more interesting when the total white cell count is also low or when infections are unusually frequent.
Total white cells first, since they anchor the percentage, then basophils as the other granulocyte involved in allergic signalling. Hemoglobin, RBC and hematocrit from the same complete blood count help separate a genuine white cell change from other shifts. Vitamin D is often tracked alongside, because vitamin D status may relate to allergic inflammation.
There is no single schedule that suits everyone, and the right interval depends on why the marker was flagged and what symptoms accompany it. In practice, a repeat after several weeks is a reasonable way to tell a one-off from a pattern, and regular panel testing builds a trend line that is far more useful than any isolated value. A clinician can advise on timing for your situation.